CSIMarket Company Name, Ticker, Industry, else..
 
Burning Rock Biotech Limited  (NASDAQ: BNR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $9.4250 $-0.02 -0.265%
Day's High: $9.680000305175781 Week Perf: -9.72 %
Day's Low: $ 9.43 30 Day Perf: 6.62 %
Volume (M): 2,468 52 Wk High: $ 41.72
Volume (M$): $ 0 52 Wk Avg: $15.95
Open: $9.68 52 Wk Low: $6.79



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) 77
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Burning Rock Biotech Limited is a leading precision oncology company based in China. The company specializes in developing and commercializing next-generation sequencing (NGS)-based cancer diagnostics and companion diagnostics. Burning Rock uses advanced genomic testing technologies to provide comprehensive and accurate characterization of tumors, enabling personalized treatment options for cancer patients. The company's innovative approach combines NGS with artificial intelligence and big data analysis to enhance the accuracy and efficiency of cancer diagnosis and treatment. Burning Rock Biotech aims to improve patient outcomes and contribute to the advancement of precision medicine in the field of oncology.


   Company Address: No. 5, Xingdao Ring Road North Zagreb 510005 City of Zagreb
   Company Phone Number: 3403 7871   Stock Exchange / Ticker: NASDAQ BNR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EXAS        0.29% 
FTRE   -0.05%    
GH   -2.75%    
MDXH   -7.69%    
NTRA   -3.9%    
VCYT   -0.79%    
• View Complete Report
   



Management Announcement

Amidst Financial Turmoil, Burning Rock and Bayer Forge Ahead with First NGS-Based Lung Cancer Diagnostic Approved by NMPA,

Published Fri, Oct 11 2024 3:17 AM UTC

NMPA Approval of First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer Comes Amidst Financial Turbulence for Burning Rock BiotechIn a landmark achievement for the intersection of healthcare and technological innovation, the National Medical Products Administration (NMPA) in China has granted marketing approval for the first co-developed next-generation sequencing...
Partnership

Driving Precision Medicine Accessibility: Bayer and Burning Rock Join Forces

Published Thu, May 30 2024 7:42 AM UTC

In today s era of advanced healthcare, precision medicine has emerged as a game-changer in the treatment of cancer. The efficient matching of patients with personalized therapies has the potential to revolutionize outcomes. In a significant development, pharmaceutical giant Bayer and precision oncology company Burning Rock have joined hands to enhance patient access to preci...
Stock Market Announcement

Burning Rock Biotech's AGM to Address Investor Concerns Amidst Shares Decline

Published Wed, Nov 22 2023 7:05 AM UTC

Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
Burning Rock Biotech Limited, a leading company in the field of molecular diagnostics, recently released news about its upcoming Annual General Meeting (AGM) to be held on December 20, 2023. The company s AGM is an essential event where shareholders can engage with management, discuss the ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.95
Working Capital Ratio 3.14
Leverage Ratio (MRQ) 0.53
Total Debt to Equity 0
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 2.93
Inventory Turnover Ratio (TTM) 3.39
Asset Turnover Ratio (TTM) 0.57

Profitability Ratios Current
Gross Margin (MRQ) 74.67 %
Operating Margin (MRQ) -10.17 %
Net Margin (MRQ) -10.26 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Burning Rock Biotech Limited's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.